The effect of backbone cyclization on PK/PD properties of bioactive peptide-peptoid hybrids: The melanocortin agonist paradigm

General structure of peptides, peptoids, peptomers and backbone cyclic peptomers. A peptide–peptoid hybrid (peptomer) library was designed and synthesized, based on the sequence Phe- d-Phe-Arg-Trp-Gly. This sequence was previously found to specifically activate the melanocortin-4-receptor (MC4R) whi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry 2010-01, Vol.18 (2), p.580-589
Hauptverfasser: Ovadia, Oded, Linde, Yaniv, Haskell-Luevano, Carrie, Dirain, Marvin L., Sheynis, Tanya, Jelinek, Raz, Gilon, Chaim, Hoffman, Amnon
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 589
container_issue 2
container_start_page 580
container_title Bioorganic & medicinal chemistry
container_volume 18
creator Ovadia, Oded
Linde, Yaniv
Haskell-Luevano, Carrie
Dirain, Marvin L.
Sheynis, Tanya
Jelinek, Raz
Gilon, Chaim
Hoffman, Amnon
description General structure of peptides, peptoids, peptomers and backbone cyclic peptomers. A peptide–peptoid hybrid (peptomer) library was designed and synthesized, based on the sequence Phe- d-Phe-Arg-Trp-Gly. This sequence was previously found to specifically activate the melanocortin-4-receptor (MC4R) which participates in regulation of energy homeostasis and appetite. The library of peptomers included a peptoid bond in the Phe and/or d-Phe position and consisted of linear and backbone cyclic analogs, differed in their ring size. While the linear peptides rapidly degraded in serum and in brush border membrane vesicles (BBMV’s), the linear peptomers were more stable. Backbone cyclic peptomers were also stable under the same conditions. Backbone cyclization significantly increased the intestinal permeability of two peptomers compared to their linear counterparts, in the Caco-2 model. Pharmacological evaluation revealed that two linear and one backbone cyclic peptomer, were found active towards MC4R at the nanomolar range. Thus, the conformational constrains imposed by these local and global modifications affect both the pharmacokinetic and pharmacodynamic properties of the parent peptide. This study demonstrates the potential of imposing backbone cyclization on bioactive peptomers as a promising approach in developing an orally available peptidomimetic drug leads.
doi_str_mv 10.1016/j.bmc.2009.12.010
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733910406</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0968089609010943</els_id><sourcerecordid>733910406</sourcerecordid><originalsourceid>FETCH-LOGICAL-c448t-cacd856bd2e4a4fec7c84ba6401e385920a6ac1eeaf60904da74a80c68dbfba93</originalsourceid><addsrcrecordid>eNp9kcFu1DAQhi0EotvCA3BBviBOSe3E643hVBUKiEr0UM7WZDxpvSRxsLOVlgPPjsMucEOyNJfv_zX-hrEXUpRSSH2-LdsBy0oIU8qqFFI8YiuptCrq2sjHbCWMbgrRGH3CTlPaCiEqZeRTdpIja71WasV-3t4Tp64jnHnoeAv4rQ0jcdxj73_A7MPI87v5fH7zjk8xTBRnT-k36wPg7B-ITzTN3lGxzOAdv9-30bv0hi_lA_UwBgw5N3K4C6NPM58ggvN3wzP2pIM-0fPjPGNfr97fXn4srr98-HR5cV2gUs1cIKBr1rp1FSlQedkNNqoFrYSkulmbSoAGlETQaWGEcrBR0AjUjWu7Fkx9xl4fevMXvu8ozXbwCanPq1HYJbtZjAkldCblgcQYUorU2Sn6AeLeSmEX63Zrs3W7WLeystl6zrw8tu_agdzfxB_NGXh1BCAh9F2EEX36x1W13kizFL09cJRdPHiKNqGnEcn5mC9kXfD_WeMXYhmh-w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733910406</pqid></control><display><type>article</type><title>The effect of backbone cyclization on PK/PD properties of bioactive peptide-peptoid hybrids: The melanocortin agonist paradigm</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Ovadia, Oded ; Linde, Yaniv ; Haskell-Luevano, Carrie ; Dirain, Marvin L. ; Sheynis, Tanya ; Jelinek, Raz ; Gilon, Chaim ; Hoffman, Amnon</creator><creatorcontrib>Ovadia, Oded ; Linde, Yaniv ; Haskell-Luevano, Carrie ; Dirain, Marvin L. ; Sheynis, Tanya ; Jelinek, Raz ; Gilon, Chaim ; Hoffman, Amnon</creatorcontrib><description>General structure of peptides, peptoids, peptomers and backbone cyclic peptomers. A peptide–peptoid hybrid (peptomer) library was designed and synthesized, based on the sequence Phe- d-Phe-Arg-Trp-Gly. This sequence was previously found to specifically activate the melanocortin-4-receptor (MC4R) which participates in regulation of energy homeostasis and appetite. The library of peptomers included a peptoid bond in the Phe and/or d-Phe position and consisted of linear and backbone cyclic analogs, differed in their ring size. While the linear peptides rapidly degraded in serum and in brush border membrane vesicles (BBMV’s), the linear peptomers were more stable. Backbone cyclic peptomers were also stable under the same conditions. Backbone cyclization significantly increased the intestinal permeability of two peptomers compared to their linear counterparts, in the Caco-2 model. Pharmacological evaluation revealed that two linear and one backbone cyclic peptomer, were found active towards MC4R at the nanomolar range. Thus, the conformational constrains imposed by these local and global modifications affect both the pharmacokinetic and pharmacodynamic properties of the parent peptide. This study demonstrates the potential of imposing backbone cyclization on bioactive peptomers as a promising approach in developing an orally available peptidomimetic drug leads.</description><identifier>ISSN: 0968-0896</identifier><identifier>EISSN: 1464-3391</identifier><identifier>DOI: 10.1016/j.bmc.2009.12.010</identifier><identifier>PMID: 20056544</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ltd</publisher><subject>Backbone cyclization ; Biological and medical sciences ; Biological Transport - drug effects ; Caco-2 Cells ; Cell Line ; Cell Membrane Permeability - drug effects ; Cyclization ; Humans ; Medical sciences ; Melanocortin ; Molecular Conformation ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Peptide Library ; Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems ; Peptides, Cyclic - chemical synthesis ; Peptides, Cyclic - chemistry ; Peptides, Cyclic - pharmacology ; Peptomers ; Pharmacology. Drug treatments ; Receptor, Melanocortin, Type 4 - agonists</subject><ispartof>Bioorganic &amp; medicinal chemistry, 2010-01, Vol.18 (2), p.580-589</ispartof><rights>2009 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright 2009 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c448t-cacd856bd2e4a4fec7c84ba6401e385920a6ac1eeaf60904da74a80c68dbfba93</citedby><cites>FETCH-LOGICAL-c448t-cacd856bd2e4a4fec7c84ba6401e385920a6ac1eeaf60904da74a80c68dbfba93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bmc.2009.12.010$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22367190$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20056544$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ovadia, Oded</creatorcontrib><creatorcontrib>Linde, Yaniv</creatorcontrib><creatorcontrib>Haskell-Luevano, Carrie</creatorcontrib><creatorcontrib>Dirain, Marvin L.</creatorcontrib><creatorcontrib>Sheynis, Tanya</creatorcontrib><creatorcontrib>Jelinek, Raz</creatorcontrib><creatorcontrib>Gilon, Chaim</creatorcontrib><creatorcontrib>Hoffman, Amnon</creatorcontrib><title>The effect of backbone cyclization on PK/PD properties of bioactive peptide-peptoid hybrids: The melanocortin agonist paradigm</title><title>Bioorganic &amp; medicinal chemistry</title><addtitle>Bioorg Med Chem</addtitle><description>General structure of peptides, peptoids, peptomers and backbone cyclic peptomers. A peptide–peptoid hybrid (peptomer) library was designed and synthesized, based on the sequence Phe- d-Phe-Arg-Trp-Gly. This sequence was previously found to specifically activate the melanocortin-4-receptor (MC4R) which participates in regulation of energy homeostasis and appetite. The library of peptomers included a peptoid bond in the Phe and/or d-Phe position and consisted of linear and backbone cyclic analogs, differed in their ring size. While the linear peptides rapidly degraded in serum and in brush border membrane vesicles (BBMV’s), the linear peptomers were more stable. Backbone cyclic peptomers were also stable under the same conditions. Backbone cyclization significantly increased the intestinal permeability of two peptomers compared to their linear counterparts, in the Caco-2 model. Pharmacological evaluation revealed that two linear and one backbone cyclic peptomer, were found active towards MC4R at the nanomolar range. Thus, the conformational constrains imposed by these local and global modifications affect both the pharmacokinetic and pharmacodynamic properties of the parent peptide. This study demonstrates the potential of imposing backbone cyclization on bioactive peptomers as a promising approach in developing an orally available peptidomimetic drug leads.</description><subject>Backbone cyclization</subject><subject>Biological and medical sciences</subject><subject>Biological Transport - drug effects</subject><subject>Caco-2 Cells</subject><subject>Cell Line</subject><subject>Cell Membrane Permeability - drug effects</subject><subject>Cyclization</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Melanocortin</subject><subject>Molecular Conformation</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Peptide Library</subject><subject>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</subject><subject>Peptides, Cyclic - chemical synthesis</subject><subject>Peptides, Cyclic - chemistry</subject><subject>Peptides, Cyclic - pharmacology</subject><subject>Peptomers</subject><subject>Pharmacology. Drug treatments</subject><subject>Receptor, Melanocortin, Type 4 - agonists</subject><issn>0968-0896</issn><issn>1464-3391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kcFu1DAQhi0EotvCA3BBviBOSe3E643hVBUKiEr0UM7WZDxpvSRxsLOVlgPPjsMucEOyNJfv_zX-hrEXUpRSSH2-LdsBy0oIU8qqFFI8YiuptCrq2sjHbCWMbgrRGH3CTlPaCiEqZeRTdpIja71WasV-3t4Tp64jnHnoeAv4rQ0jcdxj73_A7MPI87v5fH7zjk8xTBRnT-k36wPg7B-ITzTN3lGxzOAdv9-30bv0hi_lA_UwBgw5N3K4C6NPM58ggvN3wzP2pIM-0fPjPGNfr97fXn4srr98-HR5cV2gUs1cIKBr1rp1FSlQedkNNqoFrYSkulmbSoAGlETQaWGEcrBR0AjUjWu7Fkx9xl4fevMXvu8ozXbwCanPq1HYJbtZjAkldCblgcQYUorU2Sn6AeLeSmEX63Zrs3W7WLeystl6zrw8tu_agdzfxB_NGXh1BCAh9F2EEX36x1W13kizFL09cJRdPHiKNqGnEcn5mC9kXfD_WeMXYhmh-w</recordid><startdate>20100115</startdate><enddate>20100115</enddate><creator>Ovadia, Oded</creator><creator>Linde, Yaniv</creator><creator>Haskell-Luevano, Carrie</creator><creator>Dirain, Marvin L.</creator><creator>Sheynis, Tanya</creator><creator>Jelinek, Raz</creator><creator>Gilon, Chaim</creator><creator>Hoffman, Amnon</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20100115</creationdate><title>The effect of backbone cyclization on PK/PD properties of bioactive peptide-peptoid hybrids: The melanocortin agonist paradigm</title><author>Ovadia, Oded ; Linde, Yaniv ; Haskell-Luevano, Carrie ; Dirain, Marvin L. ; Sheynis, Tanya ; Jelinek, Raz ; Gilon, Chaim ; Hoffman, Amnon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c448t-cacd856bd2e4a4fec7c84ba6401e385920a6ac1eeaf60904da74a80c68dbfba93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Backbone cyclization</topic><topic>Biological and medical sciences</topic><topic>Biological Transport - drug effects</topic><topic>Caco-2 Cells</topic><topic>Cell Line</topic><topic>Cell Membrane Permeability - drug effects</topic><topic>Cyclization</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Melanocortin</topic><topic>Molecular Conformation</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Peptide Library</topic><topic>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</topic><topic>Peptides, Cyclic - chemical synthesis</topic><topic>Peptides, Cyclic - chemistry</topic><topic>Peptides, Cyclic - pharmacology</topic><topic>Peptomers</topic><topic>Pharmacology. Drug treatments</topic><topic>Receptor, Melanocortin, Type 4 - agonists</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ovadia, Oded</creatorcontrib><creatorcontrib>Linde, Yaniv</creatorcontrib><creatorcontrib>Haskell-Luevano, Carrie</creatorcontrib><creatorcontrib>Dirain, Marvin L.</creatorcontrib><creatorcontrib>Sheynis, Tanya</creatorcontrib><creatorcontrib>Jelinek, Raz</creatorcontrib><creatorcontrib>Gilon, Chaim</creatorcontrib><creatorcontrib>Hoffman, Amnon</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ovadia, Oded</au><au>Linde, Yaniv</au><au>Haskell-Luevano, Carrie</au><au>Dirain, Marvin L.</au><au>Sheynis, Tanya</au><au>Jelinek, Raz</au><au>Gilon, Chaim</au><au>Hoffman, Amnon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effect of backbone cyclization on PK/PD properties of bioactive peptide-peptoid hybrids: The melanocortin agonist paradigm</atitle><jtitle>Bioorganic &amp; medicinal chemistry</jtitle><addtitle>Bioorg Med Chem</addtitle><date>2010-01-15</date><risdate>2010</risdate><volume>18</volume><issue>2</issue><spage>580</spage><epage>589</epage><pages>580-589</pages><issn>0968-0896</issn><eissn>1464-3391</eissn><abstract>General structure of peptides, peptoids, peptomers and backbone cyclic peptomers. A peptide–peptoid hybrid (peptomer) library was designed and synthesized, based on the sequence Phe- d-Phe-Arg-Trp-Gly. This sequence was previously found to specifically activate the melanocortin-4-receptor (MC4R) which participates in regulation of energy homeostasis and appetite. The library of peptomers included a peptoid bond in the Phe and/or d-Phe position and consisted of linear and backbone cyclic analogs, differed in their ring size. While the linear peptides rapidly degraded in serum and in brush border membrane vesicles (BBMV’s), the linear peptomers were more stable. Backbone cyclic peptomers were also stable under the same conditions. Backbone cyclization significantly increased the intestinal permeability of two peptomers compared to their linear counterparts, in the Caco-2 model. Pharmacological evaluation revealed that two linear and one backbone cyclic peptomer, were found active towards MC4R at the nanomolar range. Thus, the conformational constrains imposed by these local and global modifications affect both the pharmacokinetic and pharmacodynamic properties of the parent peptide. This study demonstrates the potential of imposing backbone cyclization on bioactive peptomers as a promising approach in developing an orally available peptidomimetic drug leads.</abstract><cop>Amsterdam</cop><pub>Elsevier Ltd</pub><pmid>20056544</pmid><doi>10.1016/j.bmc.2009.12.010</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0968-0896
ispartof Bioorganic & medicinal chemistry, 2010-01, Vol.18 (2), p.580-589
issn 0968-0896
1464-3391
language eng
recordid cdi_proquest_miscellaneous_733910406
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Backbone cyclization
Biological and medical sciences
Biological Transport - drug effects
Caco-2 Cells
Cell Line
Cell Membrane Permeability - drug effects
Cyclization
Humans
Medical sciences
Melanocortin
Molecular Conformation
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Peptide Library
Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems
Peptides, Cyclic - chemical synthesis
Peptides, Cyclic - chemistry
Peptides, Cyclic - pharmacology
Peptomers
Pharmacology. Drug treatments
Receptor, Melanocortin, Type 4 - agonists
title The effect of backbone cyclization on PK/PD properties of bioactive peptide-peptoid hybrids: The melanocortin agonist paradigm
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T00%3A51%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effect%20of%20backbone%20cyclization%20on%20PK/PD%20properties%20of%20bioactive%20peptide-peptoid%20hybrids:%20The%20melanocortin%20agonist%20paradigm&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry&rft.au=Ovadia,%20Oded&rft.date=2010-01-15&rft.volume=18&rft.issue=2&rft.spage=580&rft.epage=589&rft.pages=580-589&rft.issn=0968-0896&rft.eissn=1464-3391&rft_id=info:doi/10.1016/j.bmc.2009.12.010&rft_dat=%3Cproquest_cross%3E733910406%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733910406&rft_id=info:pmid/20056544&rft_els_id=S0968089609010943&rfr_iscdi=true